Kansas City, KSNCT07242118Now EnrollingIRB Ready

Breast Cancer Female Clinical Trial in Kansas City, KS

Access cutting-edge breast cancer female treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.

Sponsored by University of Kansas Medical Center

Quick Self-Assessment

See if you qualify for this Kansas City location

Preparing your pre-screening questions…

Expert Care in Kansas City

Access breast cancer female specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related breast cancer female treatment provided free

Apply for This Kansas City Location

Check if you qualify for this breast cancer female clinical trial in Kansas City, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Kansas City

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Kansas City site if eligible
  4. 4Begin participation

About This Breast Cancer Female Study in Kansas City

This phase II study evaluates SABR as non-operative treatment for women aged 65+ with ER-positive, HER2-negative breast cancer ≤5 cm and no lymph node involvement. Eligible patients, including those previously on endocrine therapy, receive 5 SABR treatments, followed by monitoring of quality of life and assessment of treatment-related toxicity.

Sponsor: University of Kansas Medical Center

Who Can Participate

Inclusion Criteria

Willing and able to provide written informed consent obtained to participate in the study and HIPAA authorization for release of personal health information.
Women greater than or equal to age 65 years
Diagnosis of invasive carcinoma of breast undergoing non-operative management
Previously untreated OR previously treated with primary ET or chemotherapy, with either stable or progressive localized disease.
Tumor measuring ≤5 cm (cT1-T2) and clinically node negative
Diagnostic biopsy ER-positive (greater than or equal to 10% ER by immunohistochemistry staining)
Diagnostic biopsy HER2-negative according to ASCO/CAP guidelines (0 or 1+ following IHC staining or proven negative by in-situ hybridization)
Suitable for SABR as deemed by the treating radiation oncologist
Participants with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
Enrollment in another clinical trial is allowed if there would be no interference with interventions on this trial

Exclusion Criteria

Active treatment with systemic chemotherapy for breast cancer. Subjects will need to stop any breast cancer chemotherapy agent before enrollment to be included study.
Multicentric tumor.
Clinical or imaging evidence of distant metastases.
Prior ipsilateral breast or thoracic radiation.
Autoimmune conditions with associated radiation risks.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Kansas City?

Yes, this clinical trial (NCT07242118) has an active research site in Kansas City, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Breast Cancer Female Treatment Options in Kansas City, KS

If you're searching for breast cancer female treatment options in Kansas City, KS, this clinical trial (NCT07242118) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced breast cancer female specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all breast cancer female clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Kansas City, KS

See all breast cancer clinical trials recruiting in Kansas City — not just this study.

Browse Breast Cancer Trials in Kansas City →

Browse More Trials by Condition

Breast Cancer TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Kansas City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Kansas City, KS